Innovative Treatment Perseus PCI offers a revolutionary, immune-based cancer therapy that provides a less invasive alternative to traditional chemotherapy and radiation, appealing to healthcare providers seeking advanced patient care options.

Regulatory Progress With FDA-sanctioned trials demonstrating safety and efficacy, and existing approval in the Cayman Islands, the company is positioned for potential expansion into broader markets pending U.S. regulatory approval.

Market Differentiation As a small company with a novel treatment approach, Perseus PCI can leverage its unique technology to differentiate in the oncology treatment landscape, especially among clinics focused on innovative, minimally invasive therapies.

Growth Potential Despite current revenue below one million dollars, the emerging oncology innovation and ongoing approval process present significant growth opportunities as the treatment becomes more widely adopted.

Tech Stack & Outreach Utilizing web tools like WordPress, Google Analytics, and YouTube, Perseus PCI is effectively engaging potential customers and stakeholders, offering opportunities for targeted digital marketing and educational campaigns to increase awareness.